VA Asks Congress To Amend Medical Marijuana Bill For Veterans While Opposing Psychedelics Measure At Hearing
Idaho Senate Defeats Bill To Ban Marijuana Advertisements
Washington Governor Signs Law Exempting Medical Marijuana Patients From Paying Tax On Specified Products
Congressional Leaders Again Seek To Block D.C. Marijuana Sales, While Funding Psychedelic Studies, In New Spending Bill
Pennsylvania Prosecutor Argues Federal Gun Ban For Medical Marijuana Users ‘Is Unconstitutional, Full Stop’ In New Court Brief
Organ Donations From Marijuana Users Pose No Significant Infectious Risks, Study Finds
Study Finds Natural Psychedelic Mushrooms Produce ‘Enhanced Effects’ Compared To Synthesized Psilocybin, Suggesting Entourage Effect
Legalizing Marijuana For Adults Does Not Drive Increases In Youth Use, New Federally Funded Study Finds
Spiritual Health Practitioners Bring ‘Unique, And Uniquely Valuable’ Expertise To Psychedelic-Assisted Therapy, Study Says
Psychedelic Use Linked To ‘Lower Rates Of Psychotic Symptoms’ In Adolescents, Study Published By American Medical Association Finds
Marijuana Rolling Paper Company Seeks Content Creator To ‘Get Paid To Smoke Weed’ For $70,420 Salary
Nevada’s First Marijuana Consumption Lounge Officially Opens, With Top Lawmaker Hitting A Joint At 4:20
Rapper Killer Mike Suggests Giving Black People Control Over Marijuana Industry As A Form Of Reparations
Brooklyn Nets And New York Liberty Become First NBA And WNBA Teams To Partner With CBD Company
UFC Warns Fighters To Stop Using Marijuana ‘Immediately’ So They Aren’t Punished Under California Athletics Rules
Massachusetts Marijuana Sales Pass $7 Billion Mark As Prices Hit Record Low
U.S. Company Offers Free Psychedelics Training Services To Ukraine Health Professionals To Treat Trauma From War With Russia
New Mexico Officials Celebrate Marijuana Milestone As Sales Cross $1 Billion Mark Since Recreational Market Launched
Missouri’s Marijuana Market Tallied More Than $1.4 Billion During First Full Year Of Adult-Use Sales
Missouri Marijuana Company Argues That Workers Are Not Allowed To Unionize Due To Federal Law
VA Asks Congress To Amend Medical Marijuana Bill For Veterans While Opposing Psychedelics Measure At Hearing
Congressman Tears Into Top Biden Official Over ‘Politically Damaging’ Lack Of Marijuana Reform Progress, Urging White House To ‘Follow Through’
Top Federal Health Official Clarifies Rescheduling Marijuana Wouldn’t Decriminalize It—Which Biden Campaigned On
Pennsylvania Joint Committee Takes Up Marijuana Legalization As Governor Renews Push For Reform
Hawaii Marijuana Legalization Bill Clears Another House Committee After Passing Full Senate
Congress has cannabis questions for Biden official (Newsletter: March 21, 2024)
IRS cannabis cash memo (Newsletter: March 20, 2024)
Inside VP’s cannabis meeting at White House (Newsletter: March 19, 2024)
VP Harris talks cannabis legalization & pardons (Newsletter: March 18, 2024)
Biden official defends cannabis move in Senate hearing (Newsletter: March 15, 2024)
Published
on
By
Missouri Republican lawmakers have pre-filed a pair of bills to legalize the medical use of psilocybin and require clinical trials exploring the therapeutic potential of the psychedelic.
Sen. Holly Thompson Rehder (R) and Rep. Aaron McMullen (R) introduced similar versions of the legislation for the 2024 session, setting the stage for further consideration of psychedelics reform in the Show-Me State.
Under both proposals, adults 21 or older who are diagnosed with a qualifying condition such as post-traumatic stress disorder (PTSD) or substance misuse disorder could legally access laboratory-tested psilocybin. They also would need to be enrolled, or sought enrollment, in a Department of Health and Senior Services (DHSS) clinical trial involving the psychedelic.
The Senate version mirrors a separate House bill that advanced to the floor this year but was not ultimately enacted.
There are also numerous requirements for patients to provide DHSS with information about their diagnosis, the person who would be administering psilocybin and other details on the place and time of the treatment sessions.
Psilocybin could only be administered over a maximum of a one-year period, with the amount of the psychedelic used in that treatment capped at 150 milligrams, though qualifying patients could be also approved to continue for subsequent one-year periods.
Regulators, physicians and state agency officials would all be protected from legal consequences related to activity made lawful under the legislation.
Also, the legislation calls for DHSS to provide $2 million in grants to support “research on the use and efficacy of psilocybin.”
Eapen Thampy, a lobbyist for American Shaman and organizer of Psychedelic Missouri, told Marijuana Moment that he expects the Senate measure “will be further refined through the committee process.”
“The biggest issue with passing this proposal in 2024 will be external politics and election-year drama,” he said. “We’ve largely won the argument about the legitimacy and urgency of the need for psychedelic assisted psychotherapy.”
The measure further expands the state’s Right to Try statute to allow people with life-threatening or severely debilitating conditions to access experimental controlled substances, in addition to those with terminal illnesses as is the case under current law. It would strike language that prohibits the use of Schedule I drugs, an initial step to potentially opening up access to other substances such as additional psychedelics.
Additionally, it states that psilocybin research can be done by “an institution of higher education in this state or contract research organizations conducting trials approved by the United States Food and Drug Administration.”
Missouri has stood out as a key battleground for the psychedelics reform movement, with multiple GOP legislators championing proposals to free up access and promote research into the therapeutic potential of plant-based medicines in recent years.
Meanwhile, advocates have also been organizing conferences and other events—including a veterans-focused psychedelics panel that took place in October—to build on the momentum and raise awareness about the alternative therapies.
—
Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
This comes as the state’s marijuana market continues to mature, with combined 2023 medical and recreational cannabis sales surpassing $1.1 billion as of November, data from DHSS shows.
Missouri lawmakers recently announced that $17 million of the cannabis tax revenue the state has generated will be used to fund veterans health, drug treatment and legal aid.
Missouri’s marijuana system has also experienced considerable turbulence this year, with tens of thousands of products recalled over the allegedly illegal use of hemp-derived cannabinoids from outside the state. Last month, regulators moved to revoke the business license of Delta Extraction, the company at the center of the controversy.
The incident put state marijuana regulators on their heels regarding practices at product testing labs, which had already come under fire earlier in the year over alleged practices of “lab shopping” as producers sought higher THC potency numbers.
Another company, Retailer Point Management, which does business as Shangri-La in Columbia, recently settled a dispute with a union over 15 charges of unfair labor practices.
Meanwhile, lawmakers said last month the state’s marijuana regulators overstepped their authority when setting new rules on product branding and packaging meant to limit appeal to children.
In October, businesses also filed a lawsuit challenging the “stacked” local and county taxes that companies say is unconstitutional.
California Campaign To Legalize Psychedelics Submits Final Version Of Proposed 2024 Ballot Measure
New York Governor Vetoes Bills To Allow Hemp Seed In Animal Feed, Calling On State To Collect ‘More Information’ On Safety
New Jersey Awards $15 Million To Community Violence Intervention, Funded In Part By Marijuana Tax Revenue
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. His work has also appeared in High Times, VICE and attn.
VA Asks Congress To Amend Medical Marijuana Bill For Veterans While Opposing Psychedelics Measure At Hearing
Idaho Senate Defeats Bill To Ban Marijuana Advertisements
Washington Governor Signs Law Exempting Medical Marijuana Patients From Paying Tax On Specified Products
Congressional Leaders Again Seek To Block D.C. Marijuana Sales, While Funding Psychedelic Studies, In New Spending Bill
Organ Donations From Marijuana Users Pose No Significant Infectious Risks, Study Finds
Pennsylvania Prosecutor Argues Federal Gun Ban For Medical Marijuana Users ‘Is Unconstitutional, Full Stop’ In New Court Brief
All the cannabis news you need, all in one place. Copyright © 2017-2024 Marijuana Moment LLC ® and Tom Angell
Missouri GOP Lawmakers File Bills To Legalize Psilocybin Therapy And Fund Clinical Trials For 2024 Session – Marijuana Moment
